Olsson Lars
Vice President of Chemistry
Manufacturing and Control
Wilson Therapeutics
Sweden
Biography
Education: Ph.D., Organic Chemistry, Stockholm University. Other current assignments: Owner of RG Pharma Development. Previous assignments (last five years): Director CMC of Karo Bio AB and QA-associate of Fresenius Kabi AB. Holdings in the Company: 1,000 ordinary shares, 124,000 stock options and 10,000 performance shares LTIP 2017.
Research Interest
